BioVersys AG insider transactions
Management transactions
4
Shareholding disclosures
15
First disclosure
13.02.2025
Last disclosure
14.05.2026
Company summary
No management purchase or sale disclosed in the last 90 days.
- Latest purchase
- CHF 1’839
- Net flow 90 d
- CHF 0.00
- Top shareholder
- 5.686%
14.05.2026 · Non-executive member of the board of directors
Buys − sales
UBS Fund Management Switzerland AG
This page brings together all BioVersys AG (BIOVER) insider transactions: 4 management transactions and 15 significant shareholding disclosures published by SIX Exchange Regulation, from 13.02.2025 to 14.05.2026.
Detailed context
The insider24.ch page for BioVersys AG provides an overview of insider transactions and significant shareholding disclosures published by SIX Exchange Regulation. To date, there have been 4 management transactions and 15 significant shareholding disclosures reported, with the latest management transaction recorded on 2026-05-14. During the last 90 days, there were 0 purchases totaling CHF 0 and 0 sales totaling CHF 0. The largest declared shareholders by voting rights include UBS Fund Management Switzerland AG at 5.686%, BioVersys AG at 5.038%, Candriam at 3.91%, and ViaValor AG at 3.434%.
Insider barometer
90 days
No transaction in this window
Latest transaction
14.05.2026
Largest purchase
CHF 1’839
Largest sale
—
These figures aggregate public disclosures. They are not investment advice.
insider24.ch
Follow BioVersys AG’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
BioVersys AG insider transactions
BioVersys AG
Non-executive member of the board of directors · Registered shares
BioVersys AG
Non-executive member of the board of directors · Other securities
BioVersys AG
Non-executive member of the board of directors · Registered shares
BioVersys AG
Non-executive member of the board of directors · Registered shares
Latest shareholding disclosures
BioVersys AG
2 people · n/a n/a…
BioVersys AG
ViaValor AG · Single shareholder
BioVersys AG
Barrus AG · Single shareholder
BioVersys AG
UBS Fund Management Switzerland AG · Collective investment vehicle
BioVersys AG
Marc Jaquet · Single shareholder